Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin

In this concept paper, the authors present a unique and novel protocol to treat autoimmune diseases that may have the potential to reverse autoimmunity. It uses a combination of B cell depletion therapy (BDT), specifically rituximab (RTX) and intravenous immunoglobulin (IVIg), based on a specificall...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, A. Razzaque, Kaveri, Srinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058053/
https://www.ncbi.nlm.nih.gov/pubmed/30072982
http://dx.doi.org/10.3389/fimmu.2018.01189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058053/
https://www.ncbi.nlm.nih.gov/pubmed/30072982
http://dx.doi.org/10.3389/fimmu.2018.01189

Ejemplares similares